BCL9 (NM_004326) Human Untagged Clone
CAT#: SC303468
BCL9 (untagged)-Human B-cell CLL/lymphoma 9 (BCL9)
CNY 10,450.00
Product images
Specifications
Product Data | |
Type | Human Untagged Clone |
Tag | Tag Free |
Synonyms | LGS |
Vector | pCMV6-XL4 |
E. coli Selection | Ampicillin (100 ug/mL) |
Mammalian Cell Selection | None |
Sequence Data |
>OriGene sequence for NM_004326 edited
CTGTTTCTGCTGCAACCCGAGAGGAACTCGGTGAGCCTGTCCCGTTTGTGACTGCAAGCT CAGGATTTCAATCAATGCATTCCAGTAACCCTAAAGTGAGGAGCTCTCCATCAGGAAACA CACAGAGTAGCCCTAAGTCAAAGCAGGAGGTGATGGTCCGTCCCCCTACAGTGATGTCCC CATCTGGAAACCCCCAGCTGGATTCCAAATTCTCCAATCAGGGTAAACAGGGGGGCTCAG CCAGCCAATCCCAGCCATCCCCCTGTGACTCCAAGAGTGGGGGCCATACCCCTAAAGCAC TCCCTGGCCCAGGTGGGAGCATGGGGCTGAAGAATGGGGCTGGAAATGGTGCCAAGGGCA AGGGGAAAAGGGAGCGAAGTATTTCCGCCGACTCCTTTGATCAGAGAGATCCTGGGACTC CAAACGATGACTCTGACATTAAAGAATGTAATTCTGCTGACCACATAAAGTCCCAGGATT CCCAGCACACACCACACTCGATGACCCCATCAAATGCTACAGCCCCCAGGTCTTCTACCC CCTCCCATGGCCAAACTACTGCCACAGAGCCCACACCTGCTCAGAAGACTCCAGCCAAAG TGGTGTACGTGTTTTCTACTGAGATGGCCAATAAAGCTGCAGAAGCTGTTTTGAAGGGCC AGGTTGAAACTATCGTCTCTTTCCACATCCAGAACATTTCTAACAACAAGACAGAGAGAA GCACAGCGCCTCTGAACACACAGATATCTGCCCTTCGGAATGATCCGAAACCTCTCCCAC AACAGCCCCCAGCTCCGGCCAACCAGGACCAGAATTCTTCCCAGAATACCAGACTGCAGC CAACTCCACCCATTCCGGCACCAGCACCCAAGCCTGCCGCACCCCCACGTCCCCTGGACC GGGAGAGTCCTGGGGTAGAAAACAAACTGATTCCTTCTGTAGGAAGTCCTGCCAGCTCCA CTCCACTGCCCCCAGATGGTACTGGGCCCAACTCAACTCCCAACAATAGGGCAGTGACCC CTGTCTCCCAGGGGAGCAATAGCTCTTCAGCAGATCCCAAAGCCCCTCCGCCTCCACCAG TGTCCAGTGGCGAGCCCCCCACACTGGGAGAGAATCCCGATGGCCTATCTCAGGAGCAGC TGGAGCACCGGGAGCGCTCCTTACAAACTCTCAGAGATATCCAGCGCATGCTTTTTCCTG ATGAGAAAGAATTCACAGGAGCACAAAGTGGGGGACCGCAGCAGAATCCTGGGGTATTAG ATGGGCCTCAGAAAAAACCAGAAGGGCCAATACAGGCCATGATGGCCCAATCCCAAAGCC TAGGTAAGGGACCTGGGCCCCGGACAGACGTGGGAGCTCCATTTGGCCCTCAAGGACATA GAGATGTACCCTTTTCTCCAGATGAAATGGTTCCACCTTCTATGAACTCCCAGTCTGGGA CCATAGGACCCGACCACCTTGACCATATGACTCCCGAGCAGATAGCGTGGCTGAAACTGC AGCAGGAGTTTTATGAAGAGAAGAGGAGGAAGCAGGAACAAGTGGTTGTCCAGCAGTGTT CCCTCCAGGACATGATGGTCCATCAGCACGGGCCTCGGGGAGTGGTCCGAGGACCCCCCC CTCCATACCAGATGACCCCTAGTGAAGGCTGGGCACCTGGGGGTACAGAGCCATTTTCTG ATGGTATCAACATGCCACATTCTCTGCCCCCGAGGGGCATGGCTCCCCACCCCAACATGC CAGGGAGCCAGATGCGCCTCCCTGGATTTGCAGGCATGATAAACTCTGAAATGGAAGGGC CGAATGTCCCCAACCCTGCATCTAGACCAGGTCTTTCTGGAGTCAGTTGGCCAGATGATG TGCCAAAAATCCCAGATGGTCGAAATTTTCCTCCTGGCCAGGGCATTTTCAGCGGTCCTG GCCGAGGGGAACGCTTCCCAAACCCCCAAGGATTGTCTGAAGAGATGTTTCAGCAGCAGC TGGCAGAGAAACAGCTGGGTCTCCCCCCAGGGATGGCCATGGAAGGCATCAGGCCCAGCA TGGAGATGAACAGGATGATTCCAGGCTCCCAGCGCCACATGGAGCCTGGGAATAACCCCA TTTTCCCTCGAATACCAGTTGAGGGCCCTCTGAGTCCTTCTAGGGGTGACTTTCCAAAAG GAATTCCCCCACAGATGGGCCCTGGTCGGGAACTTGAGTTTGGGATGGTTCCTAGTGGGA TGAAGGGAGATGTCAATCTAAATGTCAACATGGGATCCAACTCTCAGATGATACCTCAGA AGATGAGAGAGGCTGGGGCGGGCCCTGAGGAGATGCTGAAATTACGCCCAGGTGGCTCAG ACATGCTGCCTGCTCAGCAGAAGATGGTGCCACTGCCATTTGGTGAGCACCCCCAGCAGG AGTATGGCATGGGCCCCAGACCATTCCTTCCCATGTCTCAGGGTCCAGGCAGCAACAGTG GCTTGCGGAATCTCAGAGAACCAATTGGGCCCGACCAGAGGACTAACAGCCGGCTCAGTC ATATGCCACCACTACCTCTCAACCCTTCCAGTAACCCCACCAGCCTCAACACAGCTCCTC CAGTTCAGCGCGGCCTGGGGCGGAAGCCCTTGGATATATCTGTGGCAGGCAGCCAGGTGC ATTCCCCAGGCATTAACCCTCTGAAGTCTCCCACGATGCACCAAGTCCAGTCACCAATGC TGGGCTCGCCCTCGGGGAACCTCAAGTCCCCCCAGACTCCATCGCAGCTGGCAGGCATGC TGGCGGGCCCAGCTGCTGCTGCTTCCATTAAGTCCCCCCCTGTTTTGGGGTCTGCTGCTG CTTCACCTGTCCACCTCAAGTCTCCATCACTTCCTGCCCCGTCACCTGGATGGACCTCTT CTCCAAAACCTCCCCTTCAGAGTCCTGGGATCCCTCCAAACCATAAAGCACCCCTCACCA TGGCCTCCCCAGCCATGCTGGGAAATGTAGAGTCAGGTGGCCCCCCACCTCCTACAGCCA GCCAGCCTGCCTCTGTGAATATCCCTGGAAGTCTTCCCTCTAGTACACCTTATACCATGC CTCCAGAGCCAACCCTTTCCCAGAACCCACTCTCTATTATGATGTCTCGAATGTCCAAGT TTGCAATGCCCAGTTCCACCCCGTTATACCATGATGCTATCAAGACTGTGGCCAGCTCAG ATGACGACTCCCCTCCAGCTCGTTCTCCCAACTTGCCATCAATGAATAATATGCCAGGAA TGGGCATTAATACACAGAATCCTCGAATTTCAGGTCCAAACCCCGTGGTTCCGATGCCAA CCCTCAGCCCAATGGGAATGACCCAGCCACTTTCTCACTCCAATCAGATGCCCTCTCCAA ATGCCGTGGGACCCAACATACCTCCTCATGGGGTCCCAATGGGGCCTGGCTTGATGTCAC ACAATCCTATCATGGGGCATGGGTCCCAGGAGCCACCGATGGTACCTCAAGGACGGATGG GCTTCCCCCAGGGCTTCCCTCCAGTACAGTCTCCCCCACAGCAGGTTCCATTCCCTCACA ATGGCCCCAGTGGGGGGCAGGGCAGCTTCCCAGGAGGGATGGGTTTCCCAGGAGAAGGCC CCCTTGGCCGCCCCAGCAACCTGCCCCAAAGTTCAGCAGATGCAGCACTTTGCAAGCCTG GAGGCCCCGGGGGTCCTGACTCCTTCACTGTCCTGGGGAACAGCATGCCTTCGGTGTTTA CAGACCCAGATCTGCAGGAGGTCATCCGACCTGGAGCCACCGGAATACCTGAGTTTGATC TATCCCGCATTATTCCATCTGAGAAGCCCAGCCAGACGCTGCAATATTTCCCTCGAGGGG AAGTTCCAGGCCGTAAACAGCCCCAGGGTCCTGGACCTGGGTTTTCACACATGCAGGGGA TGATGGGCGAACAAGCCCCCAGAATGGGACTAGCATTACCTGGCATGGGAGGTCCAGGGC CAGTGGGAACTCCGGACATCCCTCTTGGTACAGCTCCATCCATGCCAGGCCACAACCCCA TGAGACCACCAGCCTTTCTCCAACAAGGCATGATGGGACCTCACCATCGGATGATGTCAC CAGCACAATCTACAATGCCCGGCCAGCCCACCCTGATGAGCAATCCAGCTGCTGCCGTGG GCATGATTCCTGGCAAGGATCGGGGGCCTGCCGGGCTCTACACCCACCCTGGGCCTGTGG GCTCTCCAGGCATGATGATGTCCATGCAGGGCATGATGGGACCCCAACAGAACATCATGA TCCCCCCACAGATGAGGCCCCGGGGCATGGCTGCTGACGTGGGCATGGGTGGATTTAGCC AAGGACCTGGCAACCCAGGAAACATGATGTTTTAAGCTGCTAAGATGGGATGTGCCGATC CTTGTCAAAATGAGATTCCAGGTCCTGAGAGCTGCTTTGAGGGAGTTCCAGGAGTACTTA CTATTGGTCATGCAATAGGAGAACAGAGACCCGAGGGCTGCTTTGGGGGAGGGGGGAACT CGAGAATGTATGGATTTACCTGAAAACAAATTATTCATTTAATCAACAGGTGTGTTTTTT TTAAGATTTATTTTTTAAAAATTATTTTTGTGGACTTGGGTATCAATGATGGCACCTACT TTTGGGAATCTGTAGCTGTGCTTTGAGAATTGCCATCGGTCATGTGTTGCACCGTTCTCT GTATGTTTACGTCCTTTGGACTGGCTTCTCCCAGGATTCTTTTCTGTTTTTGTTTTTTTG ATTTGGGCTTTATTTTTTTCTGTGTACTGTACTATATTGTAAAAGGGATTTTAGCAGAGA CTTTAGTCTTTGGGGCAAGAGGAGAACAGGAATGCTGGGCTGTTTACTTTAGGTGGAGAA TCCATCTTCAGACCTTTGGACTATTTTCTTTCAACTGCAGTGTATAGAAAAACCAAACTA CGACCTCAGAGCAGAGTATTAATGAAAAGCACAAAAAAAGGAACTAAGTTCAGCGAGGGG TGGGGGGAGGGGGGAGATTTTTCTTTTGAAAAATAATGACTCTTAGGACATTTGTTTTTC AGTTCAAGTGCTCTTCAGCACTGTCTTGTCTCCCAATATACCAACCCACTGGCACATTTT TCTCTTGTTTTCTCTCTCCGATTTTGCTCTGTCTCCTCAGTTAAGTGTTTCCTTCCTTTG TGCCCCCCGCTGGTGACCCTCTGCTTCCCTCTCTCTTTCCCTTTGGCAGCTGCAATACAC AGTGTTATTCTGGGGAAATAAATCTAGCAAAGCCTCGCCTTCCATGCCGAGCGTCCTCTT GGCTCTGAGAGGGAAAGGTCTGTCCTTGGGATGCTCTCTGGTCTTTTTTCCCCCTAAGTC TTTCTCTTTCCCATCATACCCTTCCCTGCCCACCTTGTTTTCTGTTCTCCTTTTATTAGG AATTCCCAAGTGAATTTTATTAATGTGGGAGTGGAACAGATGCTAAAAGCTATCCAGGAT TTTGTTTCTGTTTGTTTTAAATTTTGTGGTTCCTTCCCTTTCCTCCCCCTCCCATGCGTA AGACGTTCTGTGTAACCTCCATTAAATTTGGTACAAAACCACTCGCCAGAGCTGTGGTGT CAGAAAAATAAAATATATTGTTTCTTAAAAAAAAAAAAAAAAAA |
Restriction Sites | Please inquire |
ACCN | NM_004326 |
Insert Size | 5600 bp |
OTI Disclaimer | Due to the inherent nature of this plasmid, standard methods to replicate additional amounts of DNA in E. coli are highly likely to result in mutations and/or rearrangements. Therefore, OriGene does not guarantee the capability to replicate this plasmid DNA. Additional amounts of DNA can be purchased from OriGene with batch-specific, full-sequence verification at a reduced cost. Please contact our customer care team at custsupport@origene.com or by calling 301.340.3188 option 3 for pricing and delivery. The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | The open reading frame of this TrueClone was fully sequenced and found to be a perfect match to the protein associated to this reference. |
Product Components | The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water). |
Reconstitution | 1. Centrifuge at 5,000xg for 5min. 2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA. 3. Close the tube and incubate for 10 minutes at room temperature. 4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom. 5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C. |
Note | Plasmids are not sterile. For experiments where strict sterility is required, filtration with 0.22um filter is required. |
Reference Data | |
RefSeq | NM_004326.2, NP_004317.2 |
RefSeq Size | 6278 bp |
RefSeq ORF | 4281 bp |
Locus ID | 607 |
UniProt ID | O00512 |
Protein Families | Druggable Genome |
Gene Summary | BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. [provided by RefSeq, Jul 2008] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
RC219304 | BCL9 (Myc-DDK-tagged)-Human B-cell CLL/lymphoma 9 (BCL9) |
CNY 14,632.00 |
|
RC219304L1 | Lenti-ORF clone of BCL9 (Myc-DDK-tagged)-Human B-cell CLL/lymphoma 9 (BCL9) |
CNY 17,032.00 |
|
RC219304L2 | Lenti-ORF clone of BCL9 (mGFP-tagged)-Human B-cell CLL/lymphoma 9 (BCL9) |
CNY 12,730.00 |
|
RC219304L3 | Lenti-ORF clone of BCL9 (Myc-DDK-tagged)-Human B-cell CLL/lymphoma 9 (BCL9) |
CNY 12,730.00 |
|
RC219304L4 | Lenti-ORF clone of BCL9 (mGFP-tagged)-Human B-cell CLL/lymphoma 9 (BCL9) |
CNY 17,032.00 |
|
RG219304 | BCL9 (tGFP-tagged) - Human B-cell CLL/lymphoma 9 (BCL9) |
CNY 16,232.00 |